Race Oncology Ltd (RAC)
All research reports and stock updates for Race Oncology Ltd.
Research Reports
Health Care
Race Oncology Ltd (RAC)
Cancer culture
Among several pre-clinical studies underway, Race Oncology’s Zantrene drug is showing strong results in the treatment of kidney cancer.